ArticleFrontiers in chemistry2024

Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders.

Belgin Sever et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.